albendazole has been researched along with verapamil in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (7.69) | 18.2507 |
2000's | 3 (23.08) | 29.6817 |
2010's | 8 (61.54) | 24.3611 |
2020's | 1 (7.69) | 2.80 |
Authors | Studies |
---|---|
Bruno-Blanch, L; Gálvez, J; García-Domenech, R | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Freiwald, S; Jiang, Y; Jones, JP; Kaspera, R; Katayama, J; Lee, CA; Smith, E; Totah, RA; Walker, GS | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Li, F; Liu, Y; Wang, W; Wu, L; Yan, B; Zhang, Q; Zhou, H; Zhu, H | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Bassett, R; Budhraja, A; Das, S; Ling, T; Maier, J; Opferman, JT; Potts, MB; Rankovic, Z; Rivas, F; Shelat, A | 1 |
Bandopadhyay, P; Das, N; Dastidar, UG; Ganguly, D; Pal, S; Rahaman, O; Roy, S; Sinha, BP; Talukdar, A | 1 |
Beugnet, F; Gauthey, M; Kerboeuf, D | 1 |
Leitch, GJ; Scanlon, M; Shaw, A; Visvesvara, GS | 1 |
Alvarez, AI; Kim, RB; Merino, G; Prieto, JG | 1 |
Ahmed, G; Ali Shah, SW; Ali, N; Ali, W; Ghias, M; Khan, I; Shah, I | 1 |
AlGusbi, S; Demeler, J; Krücken, J; Ramünke, S; von Samson-Himmelstjerna, G | 1 |
1 review(s) available for albendazole and verapamil
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
12 other study(ies) available for albendazole and verapamil
Article | Year |
---|---|
Topological virtual screening: a way to find new anticonvulsant drugs from chemical diversity.
Topics: Anticonvulsants; Computer Simulation; Databases, Factual; Discriminant Analysis; Drug Design; Molecular Structure; Quantitative Structure-Activity Relationship | 2003 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity.
Topics: Amiodarone; Astemizole; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Danazol; Drug Discovery; Drug Interactions; Enzyme Inhibitors; Humans; Hydroxylation; In Vitro Techniques; Methylation; Microsomes, Liver; Models, Biological; Molecular Structure; Substrate Specificity; Tandem Mass Spectrometry; Terfenadine | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Improving both aqueous solubility and anti-cancer activity by assessing progressive lead optimization libraries.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Fibroblasts; High-Throughput Screening Assays; Humans; Molecular Structure; Small Molecule Libraries; Solubility; Structure-Activity Relationship; Thiazolidines; Water | 2015 |
Identification of substituted 5-membered heterocyclic compounds as potential anti-leukemic agents.
Topics: Animals; Antineoplastic Agents; Apoptosis; Caspases; Cell Line, Tumor; Drug Evaluation, Preclinical; Enzyme Induction; Heterocyclic Compounds; Humans; Leukemia; Mice; Small Molecule Libraries; Therapeutic Index | 2019 |
Development, Optimization, and In Vivo Validation of New Imidazopyridine Chemotypes as Dual TLR7/TLR9 Antagonists through Activity-Directed Sequential Incorporation of Relevant Structural Subunits.
Topics: Imidazoles; Ligands; Pyridines; Toll-Like Receptor 7; Toll-Like Receptor 9 | 2022 |
Partial in vitro reversal of benzimidazole resistance by the free-living stages of Haemonchus contortus with verapamil.
Topics: Albendazole; Animals; Anthelmintics; Calcium Channel Blockers; Drug Interactions; Drug Resistance; Haemonchus; Lethal Dose 50; Ovum; Thiabendazole; Verapamil | 1997 |
Role of P glycoprotein in the course and treatment of Encephalitozoon microsporidiosis.
Topics: Acquired Immunodeficiency Syndrome; Albendazole; Animals; Anthelmintics; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Calcium Channel Blockers; Cells, Cultured; Chlorocebus aethiops; Cyclosporine; Encephalitozoon; Encephalitozoonosis; Fluoresceins; Genes, MDR; Immunohistochemistry; Immunosuppressive Agents; Verapamil | 2001 |
The anthelminthic agent albendazole does not interact with p-glycoprotein.
Topics: Albendazole; Animals; Anthelmintics; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Biological Transport; Caco-2 Cells; Calcium Channel Blockers; Cell Line; Chromatography, High Pressure Liquid; Digoxin; Enzyme Inhibitors; Humans; LLC-PK1 Cells; Male; Mice; Mice, Knockout; Quinidine; Swine; Tissue Distribution; Verapamil | 2002 |
Anthelmintic and relaxant activities of Verbascum Thapsus Mullein.
Topics: Albendazole; Animals; Anthelmintics; Ascaridia; Atropine; Cestoda; Helminthiasis, Animal; Helminths; Jejunum; Muscle Contraction; Muscle, Smooth; Paralysis; Parasympatholytics; Plant Extracts; Potassium Chloride; Rabbits; Spasm; Vasodilator Agents; Verapamil; Verbascum | 2012 |
Analysis of putative inhibitors of anthelmintic resistance mechanisms in cattle gastrointestinal nematodes.
Topics: Albendazole; Animals; Anthelmintics; Biological Assay; Calcium Channel Blockers; Cattle; Drug Resistance; Drug Therapy, Combination; Gastrointestinal Diseases; Ivermectin; Larva; Nematoda; Nematode Infections; Ovum; Pesticide Synergists; Piperonyl Butoxide; Polymorphism, Single Nucleotide; Thiabendazole; Verapamil | 2014 |